Diagnostic Capacities for Multidrug-Resistant Tuberculosis in the World Health Organization European Region-Reference-Cited by-同舟云学术

Diagnostic Capacities for Multidrug-Resistant Tuberculosis in the World Health Organization European Region

Published:2022-11 Issue:11 Volume:24 Page:1189-1194
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Maurer Florian P.^ORCID,Shubladze Natalia^ORCID,Kalmambetova Gulmira,Felker Irina^ORCID,Kuchukhidze Giorgi,Köser Claudio U.^ORCID,Cirillo Daniela Maria,Drobniewski Francis,Yedilbayev Askar,Ehsani Soudeh^ORCID,Avellón Ana,Chulanov Vladimir,Cirillo Daniela Maria,Drobniewski Francis,Felker Irina,Kalmambetova Gulmira,Köser Claudio U.,Maurer Florian P.,Niemann Stefan,Noroc Ecaterina,Paredes Roger,Shubladze Natalia,Simões Daniel,Skrahina Alena,Stanojevic Maja

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference23 articles.

1. WHO Global Tuberculosis Report 2020,2020

2. Tuberculosis Surveillance and Monitoring in Europe 2021–2019 Data,2021

3. Final Report on Implementation of the Tuberculosis Action Plan for the WHO European Region 2016–2020,2020

4. WHO Consolidated Guidelines on Tuberculosis. Module 4: Treatment - Drug-Resistant Tuberculosis Treatment,2020

5. Acquired resistance to bedaquiline and delamanid in therapy for tuberculosis;Bloemberg;N Engl J Med,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overview;Tuberculosis;2024-09

2. A composite reference standard is needed for bedaquiline antimicrobial susceptibility testing forMycobacterium tuberculosiscomplex;European Respiratory Journal;2024-07

3. Predisposing, enabling, and need factors influencing rapid uptake of the World Health Organization-endorsed TB diagnostic technologies in Africa;2024-03-04

4. Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland;Respiration;2024

5. Mind the gap. Rolling out new drug resistant tuberculosis regimens with limited diagnostic tools;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2023-08